BioSpace News Archive

- Autolus Therapeutics plc (NASDAQ: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced that it has signed a long-term, full-building lease with Alexandria Real Estate Equities, Inc. (NYSE: ARE) for the construction and development of an 85,000 square foot build-to-suit facility

Astellas Pharma Canada, Inc., today announced that Health Canada approved an expanded indication for enzalutamide, an androgen receptor inhibitor for the treatment of patients with prostate cancer, following a Priority Review by Health Canada’s Therapeutic Products Directorate (TPD).

International humanitarian organizations Lutheran World Relief and IMA World Health today announced they are combining operations to dramatically increase their impact on breaking the cycle of poverty and promoting healthier families and communities throughout the world.

S&P Global Market Intelligence announced today the introduction of new alternative data set through its data feed management system, Xpressfeed™. This pharmaceutical package is a curated, sector-specific data feed which maps Panjiva supply chain data to the Food and Drug Administration’s (FDA) Orange Book.

The expanded 66,000 square foot Cancer Center was designed to provide space for the hospital’s growth and to enhance the facility’s cancer research and treatment facilities.

Curere is a patented, regenerative skin care line created to treat a range of skin conditions, including acne, third-degree burns and necrosis.

FSD fully supports Cannara’s strategic vision and expansion plans and intends to continue working in partnership with Cannara to take advantage of opportunities that benefit both companies

Bio-Thera intends to file for regulatory approval with the China National Medical Products Administration, the European Medicines Agency and the United States Food and Drug Administration in 2020.

Company’s global commercialization plans for GoodWheat™ portfolio of innovative wheat ingredients remain on track

At the 2019 Consumer Electronics Show (CES), EEGSmart, which is the first EEG-centered professional bioinformatics sensor and artificial intelligence solution provider in China, debuted its Mini Electroencephalogram (EEG) Sleep Monitor, UMindSleep, attracting a great deal of attention from industry attendees.